Jan 22, 2018 5:05 pm EST Acasti Pharma Announces the Closing of Over-Allotment Option for its Public Offering of Common Shares
Jan 8, 2018 7:00 am EST Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures
Jan 4, 2018 8:00 am EST Acasti Expands Global Patent Portfolio with Newly Granted Patents in South Korea and Canada
Dec 27, 2017 4:05 pm EST Acasti Pharma Announces Closing of US$10 Million Firm Commitment Offering of Common Shares and Warrants
Dec 21, 2017 8:38 am EST Acasti Pharma Announces Pricing of US$10 Million Offering of Common Shares and Warrants
Nov 22, 2017 8:00 am EST Acasti Pharma Clarifies Term of Proposed Strategic Partnership with Leading China Pharmaceutical Company
Nov 20, 2017 8:00 am EST Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China Pharmaceutical Partner